SCHEMBL9763414

SCHEMBL9763414

O=C(O)C(S)C(CC(CO)(CO)CO)(C(S)C(=O)O)C(S)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNPEP Q9H4A4 3/20 0.34
FOLH1 Q04609 1/20 0.34
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
ABCB11 O95342 1/20 0.33
F2 P00734 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
KMT2A Q03164 1/20 0.33
DUSP3 P51452 1/20 0.33
PTPN5 P54829 1/20 0.33
PTPN11 Q06124 1/20 0.33
LMNA P02545 1/20 0.33
CYP2C9 P11712 1/20 0.33
HIF1A Q16665 1/20 0.33
GABRR1 P24046 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10351699 0.76 ALDH1A1 (0.31) ALDH1A1HIF1A
SCHEMBL16581578 0.76 SLC22A6 (0.32) FOLH1TDP1
SCHEMBL2770550 0.74 TDP1 (0.40) RNPEPFOLH1HPGDHSD17B10TDP1
SCHEMBL2202864 0.72 FOLH1 (0.44) RNPEPFOLH1HPGDHSD17B10TDP1
SCHEMBL29092215 0.72 RNPEP (0.39) RNPEPFOLH1HPGDHSD17B10TDP1
SCHEMBL8997938 0.71 RNPEP (0.50) RNPEPFOLH1HPGDHSD17B10TDP1
SCHEMBL1849072 0.70 RNPEP (0.42) RNPEPHPGDHSD17B10TDP1ABCB11
SCHEMBL1171013 0.70 RNPEP (0.42) RNPEPFOLH1HPGDHSD17B10TDP1
SCHEMBL432443 0.70 RNPEP (0.37) RNPEPFOLH1HPGDHSD17B10TDP1
SCHEMBL467265 0.70 RNPEP (0.42) RNPEPFOLH1HPGDHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3696216-A1 FOAMABLE, SEAL-LAYER FORMING MULTICOMPONENT COMPOSITION AND ITS USE Hilti Aktiengesellschaft (LI) 2020-08-19 EP claimed
EP-3158012-B1 FIRE-RESISTANT COMPOUND AND ITS UTILISATION HILTI AG (LI) 2020-02-19 EP claimed
US-10392516-B2 Fire protection composition and use thereof HILTI AKTIENGESELLSCHAFT (LI) 2019-08-27 US claimed
US-10287504-B2 Composition that forms an insulating layer and use thereof HILTI AKTIENGESELLSCHAFT (LI) 2019-05-14 US claimed
EP-2935475-B1 INSULATING LAYER-FORMING COMPOSITION AND USE THEREOF HILTI AG (LI) 2017-07-19 EP claimed
US-20170145223-A1 Fireproof Composition and Use Thereof HILTI AKTIENGESELLSCHAFT (LI) 2017-05-25 US claimed
US-20170130068-A1 Fireprotection Composition and Use Thereof HILTI AKTIENGESELLSCHAFT (LI) 2017-05-11 US claimed
US-20170130066-A1 Fire Protection Composition and Use Thereof HILTI AKTIENGESELLSCHAFT (LI) 2017-05-11 US claimed
EP-2957604-A1 Fire-resistant compound and its utilisation HILTI Aktiengesellschaft (LI) 2015-12-23 EP claimed
EP-2957606-A1 Fire-resistant compound and its utilisation HILTI Aktiengesellschaft (LI) 2015-12-23 EP claimed
EP-2957605-A1 Fire-resistant compound and its utilisation HILTI Aktiengesellschaft (LI) 2015-12-23 EP claimed
US-20150337160-A1 INSULATING LAYER-FORMING COMPOSITION AND THE USE THEREOF HILTI AKTIENGESELLSCHAFT (LI) 2015-11-26 US claimed
US-20150299578-A1 COMPOSITION THAT FORMS AN INSULATING LAYER AND USE THEREOF HILTI AKTIENGESELLSCHAFT (LI) 2015-10-22 US claimed
US-20240199770-A1 CURABLE COMPOSITION COMPRISING A PHOTOINITIATOR ARKEMA FRANCE (FR) 2024-06-20 US disclosed
EP-3712219-B1 FLAME RETARDANT COMPOUND AND USE OF SAME HILTI AG (LI) 2022-01-26 EP disclosed
US-10995219-B2 Free radical-curable coating and sealant compositions with improved surface cure properties ARKEMA FRANCE (FR) 2021-05-04 US disclosed
US-20150299578-A1 COMPOSITION THAT FORMS AN INSULATING LAYER AND USE THEREOF HILTI AKTIENGESELLSCHAFT (LI) 2015-10-22 US disclosed
EP-2851352-A1 Reaction-resin mortar curable by head to tail polymerisation and method for fixing anchor rods HILTI Aktiengesellschaft (LI) 2015-03-25 EP disclosed
EP-0246190-B1 DERIVATIVES OF ISOCYANURIC ACID CIBA-GEIGY AG (CH) 1991-12-04 EP disclosed
EP-0246190-A2 Derivatives of isocyanuric acid CIBA-GEIGY AG (CH) 1987-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199770-A1 CURABLE COMPOSITION COMPRISING A PHOTOINITIATOR EED, CDH1, EPB41 RNPEP 4758/4885FOLH1 3851/4885HPGD 1551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.